Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Michael McIntyre Reveals Slimmer Figure After Using Mounjaro - Featured image
Health & Wellness

Michael McIntyre Reveals Slimmer Figure After Using Mounjaro

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·November 8, 2025·2 min read

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Michael McIntyre recently showcased his weight loss transformation in London, attributing it to the use of Mounjaro. He openly discussed his journey, including initial reluctance and subsequent positive results. He also commented on others using similar methods.

Share

Michael McIntyre Reveals Slimmer Figure After Using Mounjaro

Michael McIntyre recently unveiled his notable weight loss in London, sharing that he had been prescribed Mounjaro.

The comedian, 49, was photographed leaving Scott's restaurant in Mayfair on Friday afternoon. He sported navy suit trousers, a long black coat, and a fleece jacket as he stood outside the popular celebrity spot.

An onlooker recognized the presenter of The Wheel and approached him for a photograph. McIntyre happily obliged, engaging in a friendly chat and posing for pictures.

His weight loss was evident, showcasing a slimmer physique after recently discussing his use of Mounjaro, a weight-loss medication.

McIntyre openly shared that his weight had reached 100kg (15st 10lbs) before commencing the injections.

Furthermore, he humorously commented on celebrities who opt for such treatments, remarking that they sometimes 'look sh*t'.

McIntyre initiated weight loss injections following a doctor's warning that he was obese.

The presenter admitted initial hesitation towards the medication. However, his wife, Kitty, encouraged him to pursue it after the diagnosis.

McIntyre, whose weight has varied over time, explained that he initially used Ozempic before transitioning to Mounjaro, observing weight reduction within just three weeks. Health tracking apps like Shotlee can help monitor progress with weight loss medications.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

He commented, 'I do look a bit better now. I look good. I am kind of sexy now, a little bit. Not too much.'

He humorously addressed celebrities who 'cheat to be thin,' stating, 'I did it for three weeks, some people do it for years.'

'This is what is happening. Very big people have become very small people right?'

'And it does not suit everyone. Isn't that terrible when somebody loses all the weight they have been waiting to lose and they look a bit sh*t.

'Sometimes a big nose can be hidden by big cheeks and when the cheeks go down it is like "What the f*ck is going on?" and they are like a parrot.'

McIntyre maintained that his weight gain stemmed from consuming leftovers from his two sons, Lucas, 20, and Oscar, 18.

He also confessed that while the appetite suppressant was currently effective, he anticipated his progress would 'fall apart' if he succumbed to his sweet cravings again.

According to the NHS, a BMI between 30 and 39.9 indicates obesity for most adults, while a BMI above 40 signifies morbid obesity.

Source Information

Originally published by Daily Mail Online.Read the original article →

Read next

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: weight management

All weight management articles →
New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It
Wellness & Health

New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It

New York City is experiencing a surge in peptide therapy requests via telehealth platforms. This article explores the most popular compounds, safety protocols, and how to track results effectively.

8 min read
Semaglutide for Weight Loss in Adults Over 65: New Study Findings
Weight Management

Semaglutide for Weight Loss in Adults Over 65: New Study Findings

A recent analysis of the STEP trials reveals that semaglutide, the active ingredient in popular medications like Ozempic and Wegovy, offers significant weight loss and health benefits for adults over 65 with obesity, with a safety profile comparable to younger populations.

8 min read

More in Health & Wellness

Dr. Oz Links Obesity to Chronic Disease Surge, Suggests GLP-1s Can 'Jumpstart' Better Health
Health & Wellness

Dr. Oz Links Obesity to Chronic Disease Surge, Suggests GLP-1s Can 'Jumpstart' Better Health

CMS Administrator Dr. Oz highlights the critical link between obesity and chronic diseases, advocating for the strategic use of GLP-1 medications to improve health and potentially cut healthcare costs.

7 min read
GLP-1 Weight-Loss Drugs Linked to Lower Risks of Addiction and Overdose
Health & Wellness

GLP-1 Weight-Loss Drugs Linked to Lower Risks of Addiction and Overdose

Explore the groundbreaking research linking GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Zepbound, to a reduced risk of substance use disorders and fewer addiction-related emergencies.

8 min read
Ozempic, Wegovy, Mounjaro: The GLP-1 Revolution in Weight Loss
Health & Wellness

Ozempic, Wegovy, Mounjaro: The GLP-1 Revolution in Weight Loss

A closer look at the groundbreaking GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, and their transformative effects on weight management and overall health.

6 min read
Share this article
  1. Home
  2. Blog
  3. Michael McIntyre Reveals Slimmer Figure After Using Mounjaro
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community